Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class | LM ID | Common Name | Systematic Name | LipidBank ID ▼ | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|---|
Acidic glycosphingolipids
|
Gangliosides
|
SSEA-4 positional isomer
|
NeuAcalpha2-6Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
|
GSG3065
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GT1aa
|
NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer
|
GSG3048
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GD3
|
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer
|
GSG3044
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GT1a
|
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer
|
GSG3043
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GD1c
|
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer
|
GSG3042
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
SSEA-4 antigen
|
NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
|
GSG3037
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GQ1b
|
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-8NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer
|
GSG3036
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
GQ1ba
|
NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer
|
GSG3035
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
sialyl-Lea
|
NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
|
GSG3034
|
||||||
Acidic glycosphingolipids
|
Gangliosides
|
VIM-II
|
NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
|
GSG3033
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01